ARQL
Arqule, Inc.
A biopharmaceutical company in Massachusetts that made targeted small-molecule cancer drugs, especially kinase inhibitors. Founded in 1993, it ran automated array-based chemistry to help big drug companies test compounds before shifting to develop its own therapies. Its name blends "array" and "quantitative" chemistry, and Merck bought the firm in 2020.
CUSIP: 04269E107HealthcareUS1 holder
Total Value
$83.40M
Total Shares
15.08M
Net Share Change
+247.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
